[Prolonged use of paclitaxel for platinum-refractory ovarian cancer--brief report]

The patient was a 41-year-old women with platinum-refractory ovarian cancer. She received 135-210 mg/m2 paclitaxel for 13 cycles. She received granulocyte colony-stimulating factor (G-CSF) support to prevent severe granulocytopenia, and experienced little neurologic toxicity. Her quality of life was good throughout the prolonged period of use of paclitaxel.